EngMab
ExitedEngMab is tracked in the Tech.eu funding database. Based in Schwyz, Switzerland; founded 2013; active in Healthtech. Acquired by Celgene in 2016. Data as of Nov 2026.
Schwyz, SwitzerlandFounded 2013
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
May 2016
Value
€545M
Acquiror
Celgene (United States Summit)